Raluca Munteanu

Iuliu Hațieganu University of Medicine and Pharmacy — Romania

Medicine · Health Sciences

14h-index735citations38works13.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(7), Acute Myeloid Leukemia Research(4), Virus-based gene therapy research(4), Epigenetics and DNA Methylation(3), Hematopoietic Stem Cell Transplantation(3)

Publications38 total

Indocyanine-Green-Guided Partial Nephrectomy: A Narrative Review Addressing Protocol Heterogeneity, Perioperative Functional and Oncological Outcomes
Medicina·2026Open Access
Proteolysis targeting chimeric-based technology in myeloma and lymphoma
Molecular Cancer Therapeutics·2026Open Access
Targeting inflammation and oxidative stress in experimental colitis through IL-6 siRNA and ascorbic acid co-loaded trimethyl chitosan nanoparticles
International Journal of Pharmaceutics·2025Open Access
CARing about autoimmune disorders. Use of chimeric antigen receptor engineered T-cells in autoimmune diseases
Blood Reviews·2025Open Access
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma
Biomarker Research·2025· 2 citedOpen Access
Challenges in the preclinical design and assessment of CAR-T cells
Frontiers in Immunology·2025· 5 citedOpen Access
Humanized mouse models in MDS
Cell Death and Disease·2025· 1 citedOpen Access
Adoptive cellular therapies in multiple myeloma
Best Practice & Research Clinical Haematology·2025Open Access
Adoptive cellular therapies in non-Hodgkin lymphomas
Best Practice & Research Clinical Haematology·2025Open Access
Therapeutic advances in the targeting of ROR1 in hematological cancers
Cell Death Discovery·2024· 17 citedOpen Access
5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity
Medicine and Pharmacy Reports·2024· 2 citedOpen Access
<scp>RNA</scp> methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high‐grade myelodysplastic syndromes
Journal of Cellular and Molecular Medicine·2024· 1 citedOpen Access
Therapeutic advances of targeting receptor tyrosine kinases in cancer
Signal Transduction and Targeted Therapy·2024· 167 citedOpen Access
Minimal Change Disease: Pathogenetic Insights from Glomerular Proteomics
International Journal of Molecular Sciences·2024· 9 citedOpen Access
Preclinical Evaluation of an Anti-CD41 CAR T Cell in Acute Megakaryoblastic Leukemia on in Vitro and In Vivo Models
Transplantation and Cellular Therapy·2024
Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective
Cancers·2023· 14 citedOpen Access
Synergistic Effect of Human Chorionic Gonadotropin and Granulocyte Colony Stimulating Factor in the Mobilization of HSPCs Improves Overall Survival After PBSCT in a Preclinical Murine Model. Are We Far Enough for Therapy?
Stem Cell Reviews and Reports·2023· 1 cited
Design and preclinical testing of an <scp>anti‐CD41 CAR</scp> T cell for the treatment of acute megakaryoblastic leukaemia
Journal of Cellular and Molecular Medicine·2023· 5 citedOpen Access
Insights into the Human Microbiome and Its Connections with Prostate Cancer
Cancers·2023· 12 citedOpen Access
Current trends in luminescence-based assessment of apoptosis
RSC Advances·2023· 11 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Diana Gulei(25), Ciprian Tomuleasa(14), Adrian Bogdan Țigu(14), Diana Cenariu(13), Anca Onaciu(12), Cristian Moldovan(11), Dávid Kegyes(11), Richard Feder(10), Delia Dima(9), Alina Tănase(9), Alina‐Andreea Zimța(8), Ioana Berindan‐Neagoe(8), Ancuța Jurj(8), Mihnea Zdrenghea(8), Mădălina Nistor(8), Gabriel Ghiaur(7), V.C. Munteanu(7), Patric Teodorescu(7), Cristina Adela Iuga(7), Cătălin Constantinescu(6)